Recent comprehensive genomic analyses demonstrated that high-risk NB tumors are characterized by MYCN amplification and/or hTERT rearrangement, which contributes to high hTERT expression and subsequent unfavorable prognosis. The gene discussed is MYCN; the disease is neuroblastoma.